Company Filing History:
Years Active: 2018-2019
Title: Vincent Rogue: Innovator in Oncology Drug Formulations
Introduction
Vincent Rogue is a notable inventor based in Bouxwiller, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of two patents to his name, Rogue is recognized for his work in oncology drug delivery systems.
Latest Patents
Vincent Rogue's latest patents focus on oral formulations and suspensions of oncology drugs. One of his key innovations involves dry powder formulations for inhalation, which are designed for the treatment of various diseases and conditions. The formulation consists of a uniform blend of two spray-dried powders. The first powder contains spray-dried particles of a therapeutically active ingredient, which is dispersed in a pharmaceutically acceptable hydrophobic excipient. The second powder is formed from a hydrophobic excipient but is substantially free of any active ingredient. This unique combination ensures that the active ingredient in the first powder is loaded sufficiently high to compensate for the absence of active ingredients in the second powder. Additionally, Rogue describes a process for preparing such formulations, showcasing his expertise in pharmaceutical innovation.
Career Highlights
Vincent Rogue is currently associated with Sun Pharma Global Fze, where he continues to advance his research and development efforts. His work has been instrumental in enhancing the efficacy of drug delivery systems, particularly in oncology. His contributions have the potential to improve patient outcomes and provide new treatment options for challenging medical conditions.
Collaborations
Vincent collaborates with Celine Decaudin, further enriching his research endeavors. Their partnership exemplifies the importance of teamwork in driving innovation in the pharmaceutical industry.
Conclusion
Vincent Rogue stands out as a dedicated inventor in the field of oncology drug formulations. His innovative approaches and patented technologies contribute significantly to advancements in pharmaceutical science. His work not only reflects his expertise but also holds promise for improving therapeutic options for patients.